Global Rubella Virus Antigen 麻豆原创 Research Report 2025

Publication ID:

PB503250575

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Rubella Virus Antigen was valued at US$ 109 million in the year 2024 and is projected to reach a revised size of US$ 136 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Rubella Virus Antigen refers to specific proteins or components of the rubella virus that are used in diagnostic tests to detect the presence of rubella virus infection in a patient. Rubella is a contagious viral infection that typically causes a mild rash and fever, but can have serious consequences when contracted by pregnant women, particularly during the first trimester, leading to birth defects or miscarriage.The Rubella Virus Antigen is often detected in laboratory tests such as enzyme-linked immunosorbent assays (ELISA) or polymerase chain reaction (PCR) methods. These antigens are primarily derived from the rubella virus鈥� coat proteins, which trigger an immune response in the body. During an infection, the immune system recognizes these antigens as foreign and produces antibodies against them.
North American market for Rubella Virus Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rubella Virus Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rubella Virus Antigen in In Vitro Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rubella Virus Antigen include Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rubella Virus Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Virus Antigen.
The Rubella Virus Antigen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rubella Virus Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Virus Antigen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Creative Biomart
RayBiotech
ProSpec
Abcam
Bio-Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation
Segment by Type
Rubella Protein Purity >90%
Rubella Protein Purity >95%
Rubella Protein Purity >98%
Others
Segment by Application
In Vitro Diagnostics
Vaccine Development
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rubella Virus Antigen company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Rubella Virus Antigen 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rubella Protein Purity >90%
1.2.3 Rubella Protein Purity >95%
1.2.4 Rubella Protein Purity >98%
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Rubella Virus Antigen 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In Vitro Diagnostics
1.3.3 Vaccine Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Virus Antigen 麻豆原创 Perspective (2020-2031)
2.2 Global Rubella Virus Antigen Growth Trends by Region
2.2.1 Global Rubella Virus Antigen 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rubella Virus Antigen Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Rubella Virus Antigen Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Rubella Virus Antigen 麻豆原创 Dynamics
2.3.1 Rubella Virus Antigen Industry Trends
2.3.2 Rubella Virus Antigen 麻豆原创 Drivers
2.3.3 Rubella Virus Antigen 麻豆原创 Challenges
2.3.4 Rubella Virus Antigen 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Virus Antigen Players by Revenue
3.1.1 Global Top Rubella Virus Antigen Players by Revenue (2020-2025)
3.1.2 Global Rubella Virus Antigen Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Rubella Virus Antigen Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rubella Virus Antigen Revenue
3.4 Global Rubella Virus Antigen 麻豆原创 Concentration Ratio
3.4.1 Global Rubella Virus Antigen 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Virus Antigen Revenue in 2024
3.5 Global Key Players of Rubella Virus Antigen Head office and Area Served
3.6 Global Key Players of Rubella Virus Antigen, Product and Application
3.7 Global Key Players of Rubella Virus Antigen, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Virus Antigen Breakdown Data by Type
4.1 Global Rubella Virus Antigen Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Rubella Virus Antigen Forecasted 麻豆原创 Size by Type (2026-2031)
5 Rubella Virus Antigen Breakdown Data by Application
5.1 Global Rubella Virus Antigen Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Rubella Virus Antigen Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Rubella Virus Antigen 麻豆原创 Size (2020-2031)
6.2 North America Rubella Virus Antigen 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rubella Virus Antigen 麻豆原创 Size by Country (2020-2025)
6.4 North America Rubella Virus Antigen 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Virus Antigen 麻豆原创 Size (2020-2031)
7.2 Europe Rubella Virus Antigen 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rubella Virus Antigen 麻豆原创 Size by Country (2020-2025)
7.4 Europe Rubella Virus Antigen 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Virus Antigen 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Rubella Virus Antigen 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rubella Virus Antigen 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Rubella Virus Antigen 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Virus Antigen 麻豆原创 Size (2020-2031)
9.2 Latin America Rubella Virus Antigen 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rubella Virus Antigen 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Rubella Virus Antigen 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Virus Antigen 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Rubella Virus Antigen 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rubella Virus Antigen 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Rubella Virus Antigen 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biomart
11.1.1 Creative Biomart Company Details
11.1.2 Creative Biomart Business Overview
11.1.3 Creative Biomart Rubella Virus Antigen Introduction
11.1.4 Creative Biomart Revenue in Rubella Virus Antigen Business (2020-2025)
11.1.5 Creative Biomart Recent Development
11.2 RayBiotech
11.2.1 RayBiotech Company Details
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech Rubella Virus Antigen Introduction
11.2.4 RayBiotech Revenue in Rubella Virus Antigen Business (2020-2025)
11.2.5 RayBiotech Recent Development
11.3 ProSpec
11.3.1 ProSpec Company Details
11.3.2 ProSpec Business Overview
11.3.3 ProSpec Rubella Virus Antigen Introduction
11.3.4 ProSpec Revenue in Rubella Virus Antigen Business (2020-2025)
11.3.5 ProSpec Recent Development
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Rubella Virus Antigen Introduction
11.4.4 Abcam Revenue in Rubella Virus Antigen Business (2020-2025)
11.4.5 Abcam Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Rubella Virus Antigen Introduction
11.5.4 Bio-Rad Laboratories Revenue in Rubella Virus Antigen Business (2020-2025)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Fapon Biotech
11.6.1 Fapon Biotech Company Details
11.6.2 Fapon Biotech Business Overview
11.6.3 Fapon Biotech Rubella Virus Antigen Introduction
11.6.4 Fapon Biotech Revenue in Rubella Virus Antigen Business (2020-2025)
11.6.5 Fapon Biotech Recent Development
11.7 QED Bioscience
11.7.1 QED Bioscience Company Details
11.7.2 QED Bioscience Business Overview
11.7.3 QED Bioscience Rubella Virus Antigen Introduction
11.7.4 QED Bioscience Revenue in Rubella Virus Antigen Business (2020-2025)
11.7.5 QED Bioscience Recent Development
11.8 Cusabio
11.8.1 Cusabio Company Details
11.8.2 Cusabio Business Overview
11.8.3 Cusabio Rubella Virus Antigen Introduction
11.8.4 Cusabio Revenue in Rubella Virus Antigen Business (2020-2025)
11.8.5 Cusabio Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Rubella Virus Antigen Introduction
11.9.4 Meridian Bioscience Revenue in Rubella Virus Antigen Business (2020-2025)
11.9.5 Meridian Bioscience Recent Development
11.10 Native Antigen Company
11.10.1 Native Antigen Company Company Details
11.10.2 Native Antigen Company Business Overview
11.10.3 Native Antigen Company Rubella Virus Antigen Introduction
11.10.4 Native Antigen Company Revenue in Rubella Virus Antigen Business (2020-2025)
11.10.5 Native Antigen Company Recent Development
11.11 SERION Immunologics
11.11.1 SERION Immunologics Company Details
11.11.2 SERION Immunologics Business Overview
11.11.3 SERION Immunologics Rubella Virus Antigen Introduction
11.11.4 SERION Immunologics Revenue in Rubella Virus Antigen Business (2020-2025)
11.11.5 SERION Immunologics Recent Development
11.12 ViroGen Corporation
11.12.1 ViroGen Corporation Company Details
11.12.2 ViroGen Corporation Business Overview
11.12.3 ViroGen Corporation Rubella Virus Antigen Introduction
11.12.4 ViroGen Corporation Revenue in Rubella Virus Antigen Business (2020-2025)
11.12.5 ViroGen Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative Biomart
RayBiotech
ProSpec
Abcam
Bio-Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.